Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs NuDay Rx

AM Rx
Graded #491

Lower grade

vs+17.300000000000004
NuDay Rx
Graded #182

Higher grade

The verdict

NuDay Rx takes it — 66.9/100 to 49.6/100.

NuDay Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuDay Rx is a GLP-1 weight-loss telehealth service (on the CareValidate/careGLP platform) that pairs medication with video coaching and lifestyle support.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAM Rx +2
50
48
Dose & formulationNuDay Rx +23
65
88
Clinical oversightNuDay Rx +33
41
74
Labs & monitoringNuDay Rx +13
49
62
FulfillmentNuDay Rx +15
58
73
Contract termsNuDay Rx +35
20
55
AM Rx · left barNuDay Rx · right bar

The numbers

MetricAM RxNuDay Rx
WeighScore49.6/10066.9/100
GradeCC
Scorecard rank#491#182
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)$249/mo (compounded)
TirzepatideNot disclosed$329/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
AM Rx

Graded #491 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
NuDay Rx

Graded #182 · C

Strengths

  • Wide selection — compounded semaglutide ($249) and tirzepatide ($329), oral tablet options, plus brand GLP-1 (cash pay)
  • Includes video coaching and lifestyle support with a licensed-doctor consult
  • Full legal suite published (Terms, Privacy, Privacy Practices, Medical Consent)
  • Prescription delivered to your door after an online intake and consult

Where it loses points

  • Compounded semaglutide ($249) is pricier than some budget competitors
  • Compounding pharmacy partner not named
  • Not LegitScript-certified (no certification displayed)
  • Runs on a shared white-label telehealth platform (CareValidate/careGLP)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard